Healthcare Sales & Marketing Network News: Bradycardia

Searching News Database: Bradycardia

HSMN NewsFeed - 17 Sep 2024
Boston Scientific Receives FDA Approval for Expanded Indication of INGEVITY(TM)+ Pacing Leads to Include Conduction System Pacing of the Left Bundle Branch Area
Devices Cardiology FDA

HSMN NewsFeed - 24 Jun 2024
Harmony Biosciences Receives U.S. Food And Drug Administration Approval For Wakix(R) (Pitolisant) In Pediatric Patients With Narcolepsy
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 23 Oct 2023
Medtronic receives FDA approval for extravascular defibrillator to treat abnormal heart rhythms, sudden cardiac arrest
Devices Cardiology FDA

HSMN NewsFeed - 17 Feb 2023
Medtronic Receives CE Mark for Extravascular Defibrillator System That Treats Abnormal Heart Rhythms
Devices Cardiology Regulatory

HSMN NewsFeed - 22 Dec 2022
ITC Rules Apple Violated AliveCor's Patents
Devices Cardiology Litigation

HSMN NewsFeed - 17 Oct 2022
Medtronic First to Receive FDA Approval for Pacing the Heart's Natural Conduction System
Devices Cardiology FDA

HSMN NewsFeed - 26 Sep 2022
Innocoll and DURECT Announce U.S. launch of POSIMIR(R)
Biopharmaceuticals Drug Delivery Product Launch

HSMN NewsFeed - 1 Feb 2022
FDA Clears World's First Credit-Card-Sized Personal ECG
Devices Cardiology Monitoring FDA

HSMN NewsFeed - 11 Jan 2022
AliveCor Announces Strategic Additions to Executive Team
Devices Monitoring Personnel

HSMN NewsFeed - 7 Jan 2022
NICE recommends first smartphone-based ECG for the detection of atrial fibrillation (AF) for people with suspected paroxysmal AF in an ambulatory monitoring setting
Devices Monitoring Cardiology

HSMN NewsFeed - 28 Jul 2021
BIOTRONIK's Implantable Cardiac Monitor Receives Prestigious Industry Award
Devices Cardiology

HSMN NewsFeed - 16 Apr 2021
Lilly requests revocation of emergency use authorization for bamlanivimab alone to complete transition to bamlanivimab and etesevimab together for treatment of COVID-19 in the U.S.
Biopharmaceuticals FDA

HSMN NewsFeed - 26 Feb 2021
Lilly announces additional doses of neutralizing antibody therapy purchased by U.S. government to treat COVID-19
Biopharmaceuticals

HSMN NewsFeed - 2 Feb 2021
DURECT Corporation Announces U.S. FDA Approval of POSIMIR(R) For Post-Surgical Pain Reduction for up to 72 Hours Following Arthroscopic Subacromial Decompression
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 17 Dec 2020
FDA Approves GSK's BENLYSTA as the First Medicine for Adult Patients with Active Lupus Nephritis in the US
Biopharmaceuticals FDA

HSMN NewsFeed - 23 Nov 2020
FDA Clears First of its Kind Algorithm Suite for Personal ECG
Devices Monitoring Cardiology FDA

HSMN NewsFeed - 14 Oct 2020
Harmony Biosciences Receives FDA Approval For Expanded Use Of WAKIX(R) (pitolisant) For The Treatment Of Cataplexy In Adult Patients With Narcolepsy
Biopharmaceuticals FDA

HSMN NewsFeed - 29 Jun 2020
Boston Scientific Receives FDA 510(k) Clearance for the LUX-Dx(TM) Insertable Cardiac Monitor System
Devices Cardiology Monitoring FDA

HSMN NewsFeed - 27 Aug 2019
EBR Systems Closes $30M in New Funding, John McCutcheon Joins Company as President and CEO
Devices Cardiology Venture Capital Personnel

HSMN NewsFeed - 25 Jul 2019
U.S. FDA Accepts Correvio's Resubmitted New Drug Application For Brinavess (vernakalant)
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 24 Jun 2019
Correvio Resubmits Brinavess (Vernakalant) New Drug Application to U.S. FDA for the Treatment of Patients with Recent Onset Atrial Fibrillation
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 13 May 2019
FDA Grants First Ever Clearance For Six-Lead Personal ECG Device
Devices Monitoring Cardiology FDA

HSMN NewsFeed - 6 May 2019
Abbott Launches Next-generation Detection Technology in the U.S. and Europe, Offering a Smarter Approach to 24/7 Heart Monitoring for People with Irregular Heartbeats
Devices Monitoring Cardiology Product Launch

HSMN NewsFeed - 23 Apr 2019
FDA Grants First-Ever Clearances to Detect Bradycardia and Tachycardia on a Personal ECG Device
Devices Monitoring Cardiology FDA

HSMN NewsFeed - 27 Mar 2019
Novartis receives FDA approval for Mayzent(R) (siponimod), the first oral drug to treat secondary progressive MS with active disease
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 26 Jun 2018
Salix And US WorldMeds Enter Into Exclusive Co-Promotion Agreement For Opioid Withdrawal Treatment LUCEMYRA(TM) (lofexidine)
Biopharmaceuticals Distribution

HSMN NewsFeed - 29 May 2018
Egalet Announces Large Regional Plan to Cover SPRIX(R) Nasal Spray
Biopharmaceuticals Reimbursement

HSMN NewsFeed - 29 Jan 2018
gammaCore(R) Receives FDA Clearance for the Acute Treatment of Pain Associated with Migraine Headache in Adult Patients
Devices Neurology FDA

HSMN NewsFeed - 29 Nov 2017
electroCore Completes $70 Million Series B Funding Round
Devices Neurology Venture Capital

HSMN NewsFeed - 11 Sep 2017
electroCore Announces Results from gammaCore(R) (non-invasive vagus nerve stimulator) Study in Migraine at the 18th Congress of the International Headache Society
Devices Neurology

HSMN NewsFeed - 18 Apr 2017
FDA Releases gammaCore(R), the First Non-Invasive Vagus Nerve Stimulation Therapy Applied at the Neck for Acute Treatment of Pain Associated with Episodic Cluster Headache in Adult Patients
Devices FDA

HSMN NewsFeed - 31 Aug 2016
Allergan and Adamas Announce Settlement with Amneal Related to NAMZARIC(R) Patent Litigation
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 31 Aug 2016
XALKORI(R) (Crizotinib) Receives Approval In European Union For The Treatment Of Patients With ROS1-Positive Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 9 Aug 2016
Boston Scientific Announces U.S. FDA Approval Of EMBLEM(TM) MRI S-ICD System
Devices Cardiology FDA

HSMN NewsFeed - 6 Jun 2016
Allergan Announces FDA Approval of BYVALSON(TM) (nebivolol and valsartan)
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 29 Apr 2016
Boston Scientific Receives U.S. FDA Approval For ImageReady(TM) MR-Conditional Pacing System
Devices Cardiology Radiology FDA

HSMN NewsFeed - 25 Nov 2015
Pfizer Receives European Approval to Expand Use of XALKORI(R) (crizotinib) to First-Line Treatment of Adults with ALK-Positive Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 18 Nov 2015
Pfizer Reports Positive Topline Results from Phase 3 Trial Comparing XALKORI(R) (crizotinib) to Chemotherapy in Previously Untreated East Asian Patients with ALK-Positive Advanced Non-Small Cell Lung Cancer (NSCLC)
Biopharmaceuticals Oncology

HSMN NewsFeed - 22 Oct 2015
Merrimack Announces U.S. FDA Approval of ONIVYDE(TM) (irinotecan liposome injection) for the Treatment of Patients with Metastatic Pancreatic Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 5 Oct 2015
EBR Systems Receives European CE Mark Approval for World’s First Wireless Cardiac Pacing System for Heart Failure
Devices Cardiology Regulatory

HSMN NewsFeed - 16 Sep 2015
Amgen To Acquire Privately-Held Dezima Pharma
Biopharmaceuticals Cardiology Mergers & Acquisitions

HSMN NewsFeed - 18 May 2015
Actavis Launches NAMZARIC(TM) (memantine hydrochloride extended-release and donepezil hydrochloride), a Fixed-Dose Combination Therapy for the Treatment of Moderate to Severe Alzheimer's Disease
Biopharmaceuticals Neurology Product Launch

HSMN NewsFeed - 6 May 2015
EMD Serono Initiates Co-Promotion of XALKORI(R) (crizotinib) with Pfizer in the United States
Biopharmaceuticals Oncology Distribution

HSMN NewsFeed - 30 Jun 2014
Flamel Technologies Announces FDA Approval of VAZCULEP
Biopharmaceuticals FDA

HSMN NewsFeed - 29 Apr 2014
Novartis gains FDA approval for Zykadia(TM), first therapy for patients with ALK+ NSCLC previously treated with the ALK inhibitor crizotinib
Biopharmaceuticals Oncology

HSMN NewsFeed - 18 Mar 2014
St. Jude Medical Announces Start of European Post-Approval Trial for Nanostim Leadless Pacemaker
Devices Cardiology

HSMN NewsFeed - 14 Mar 2014
Boston Scientific Announces CE Mark Approval and First Implants of Ingevity[TM] MRI Pacing Leads
Devices Cardiology Regulatory

HSMN NewsFeed - 7 Feb 2014
Covis Pharmaceuticals Announces Its New Expanded Dosage Options of LANOXIN(R) for Cardiac Patients With Mild-to-Moderate Heart Failure
Biopharmaceuticals Cardiology

HSMN NewsFeed - 6 Feb 2014
St. Jude Medical Announces First US Patient Implant of Non-Surgical, Leadless Cardiac Pacemaker
Devices Cardiology

HSMN NewsFeed - 27 Jan 2014
St. Jude Medical Announces Implant of World’s First Leadless Pacemaker in the UK
Devices Cardiology

HSMN NewsFeed - 14 Jan 2014
Ipsen to set up its own US oncology team for Somatuline(R) Depot(R) (lanreotide) Injection in neuroendocrine tumors
Biopharmaceuticals Oncology

HSMN NewsFeed - 2 Jan 2014
ZIO(R) Service Identifies Significantly More Cardiac Arrhythmias Than the Traditional Holter Monitor, According to Study Published Online in the American Journal of Medicine
Devices Cardiology Monitoring

HSMN NewsFeed - 2 Dec 2013
Forest to Acquire U.S. Marketing Rights to Saphris(R) (asenapine) from Merck
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 18 Nov 2013
Late Breaking Clinical Trial Results Show Significant Delay in Atrial Fibrillation Disease Progression with Medtronic-Exclusive Pacing Features
Devices Cardiology

HSMN NewsFeed - 8 Nov 2013
Discovery Labs Announces U.S. Commercial Launch of SURFAXIN(R) (lucinactant)
Biopharmaceuticals Product Launch

HSMN NewsFeed - 14 Oct 2013
St. Jude Medical Announces Acquisition and CE Mark Approval of World's First Leadless Pacemaker
Devices Cardiology Regulatory

HSMN NewsFeed - 4 Oct 2013
Discovery Labs Announces FDA Approval of SURFAXIN(R) (lucinactant) Updated Product Specifications
Biopharmaceuticals FDA

HSMN NewsFeed - 18 Jun 2013
Sorin Group Launches REPLY(TM) 200 Family of Pacemakers with Sleep Apnea Monitoring for Better Management of Cardiovascular Co-Morbidities1
Devices Cardiology Product Launch

HSMN NewsFeed - 20 Dec 2012
Nanostim Announces First Series of Implants of Its Novel Leadless Cardiac Pacemaker System
Devices Cardiology Interventional Cardiology

HSMN NewsFeed - 17 Dec 2012
Boston Scientific Begins Clinical Trial of Patients Implanted with INGEVITY(TM) Pacing Leads
Devices Cardiology

HSMN NewsFeed - 11 Oct 2012
BIOTRONIK Launches Implantable BioMonitor(R) -- Highest Precision in Monitoring Arrhythmias
Devices Cardiology Monitoring

HSMN NewsFeed - 29 Jun 2012
Actelion Pharmaceuticals Announces U.S. Food and Drug Administration Approval of Supplemental New Drug Application for Second Generation VELETRI(R) (epoprostenol) for Injection
Biopharmaceuticals FDA

HSMN NewsFeed - 9 May 2012
Heartbeat International and BIOTRONIK Expand Fight Against Cardiovascular Disease in Mexico
Devices Cardiology

HSMN NewsFeed - 7 May 2012
Boston Scientific Announces FDA Approval and First U.S. Implant of New Devices To Treat Bradycardia
Devices Cardiology FDA

HSMN NewsFeed - 27 Apr 2012
BIOTRONIK Evia HF-T, World's First MRI-Approved CRT Pacemaker
Devices Cardiology

HSMN NewsFeed - 17 Apr 2012
St. Jude Medical Announces First Implant in Clinical Trial for Accent MRI Pacemaker and Tendril MRI Lead System
Devices Cardiology Radiology

HSMN NewsFeed - 10 Apr 2012
Boston Scientific Announces Launch of INGENIO(TM) Family of Pacemakers in Europe
Devices Cardiology Regulatory

HSMN NewsFeed - 18 Oct 2011
EBR Systems, Inc. Appoints Allan Will President and Chief Executive Officer
Devices Personnel

HSMN NewsFeed - 31 Aug 2011
Baxter Announces FDA Approval of ARTISS Fibrin Sealant for Use in Face-Lift (Facial Rhytidectomy) Procedures
Devices FDA

HSMN NewsFeed - 18 Apr 2011
Baxter Announces the Acquisition of Prism Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 18 Apr 2011
St. Jude Medical Announces European Approval of Accent MRI Pacemaker System
Devices Cardiology Regulatory

HSMN NewsFeed - 28 Feb 2011
FDA Approves INTUNIV(R) (guanfacine) Extended-Release Tablets for Use as Adjunctive Therapy to Stimulants for the Treatment of ADHD in Children and Adolescents
Biopharmaceuticals FDA

HSMN NewsFeed - 1 Dec 2010
BIOTRONIK Expands Range of State-of-the-Art Pacing Therapies with the European Approval of the New Estella and Effecta Pacemaker Series
Devices Cardiology Regulatory

HSMN NewsFeed - 28 Sep 2010
Medtronic's Insertable Cardiac Monitor Documented Arrhythmias in Post-Heart Attack Patients
Devices Monitoring Cardiology

HSMN NewsFeed - 22 Sep 2010
Novartis gains FDA approval for Gilenya, a novel first-line multiple sclerosis treatment shown to significantly reduce relapses and delay disability progression
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 25 Jun 2010
Investigational BRINAVESS (vernakalant) for Infusion Recommended for Approval by the CHMP in the European Union (EU) for the Rapid Conversion of Recent Onset Atrial Fibrillation
Biopharmaceuticals Cardiology Regulatory

HSMN NewsFeed - 25 May 2010
Genzyme Receives FDA Approval for Lumizyme for Pompe Disease
Biopharmaceuticals FDA

HSMN NewsFeed - 12 May 2010
BIOTRONIK Evia Advanced Pacemaker Receives FDA Approval
Devices Cardiology FDA

HSMN NewsFeed - 6 Apr 2010
Baxter and Nycomed Announce FDA Approval of TachoSil(R)
Devices Surgery FDA

HSMN NewsFeed - 23 Feb 2010
Forest Laboratories Receives Decision from FDA for Supplemental New Drug Application for Bystolic(R)
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 8 Feb 2010
Sagent Pharmaceuticals Announces FDA Approval of Labetalol Hydrochloride Injection, USP
Biopharmaceuticals Generics Cardiology FDA

HSMN NewsFeed - 29 Jan 2010
Teva UK Limited Launches Lercanidipine Hydrochloride Film-Coated Tablets
Biopharmaceuticals Generics

HSMN NewsFeed - 11 Jan 2010
Interim Study Data Indicate Improved Blood Pressure Management With Cardene(R) I.V. Compared to Labetalol in Patients with Acute Stoke
Biopharmaceuticals Cardiology Neurology

HSMN NewsFeed - 14 Dec 2009
FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults
Biopharmaceuticals FDA

HSMN NewsFeed - 4 Dec 2009
FDA Approves Lilly's Zyprexa for Two Adolescent Indications
Biopharmaceuticals FDA

HSMN NewsFeed - 28 Sep 2009
sanofi-aventis: Multaq(R) (dronedarone) Recommended for Approval in the European Union
Biopharmaceuticals Cardiology Regulatory

HSMN NewsFeed - 14 Sep 2009
Schering-Plough Reports Data From SAPHRIS(R) (asenapine) Long-Term Schizophrenia Relapse Prevention Study
Biopharmaceuticals

HSMN NewsFeed - 3 Sep 2009
Shire Announces FDA Approval of Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets for the Treatment of ADHD in Children and Adolescents Aged 6 to 17
Biopharmaceuticals FDA

HSMN NewsFeed - 28 Jul 2009
MULTAQ(R) (dronedarone) for Atrial Fibrillation or Atrial Flutter Now Available in the United States
Biopharmaceuticals Cardiology

HSMN NewsFeed - 21 Jul 2009
St. Jude Medical Announces FDA Approval of Accent RF and Anthem RF Pacemakers Equipped With Wireless Technology
Devices Cardiology FDA

HSMN NewsFeed - 3 Jul 2009
Sorin Group Announces Regulatory Approval and First Implants of New-Platform FACIL and REPLY Pacemakers in Japan
Devices Cardiology Regulatory

HSMN NewsFeed - 2 Jul 2009
FDA Approves Multaq(R) for Patients with Atrial Fibrillation or Atrial Flutter
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 22 Jun 2009
BIOTRONIK: First and Only Pacemaker Platform with Fully Integrated Wireless Remote Follow-up Capabilities Introduced at Europace Congress in Berlin
Devices Cardiology Regulatory

HSMN NewsFeed - 5 Jun 2009
Single Dose Palonosetron Prevents Emesis Induced by Chemotherapy in Non-Hodgkin's Lymphoma Patients
Biopharmaceuticals Oncology

HSMN NewsFeed - 18 May 2009
AstraZeneca Announces TOPROL-XL(R) (Metoprolol Succinate) is Now Available
Biopharmaceuticals

HSMN NewsFeed - 13 May 2009
St. Jude Medical Announces European Approval of Accent RF and Anthem RF Pacemakers Equipped With Wireless Technology
Devices Cardiology Regulatory

HSMN NewsFeed - 13 Apr 2009
Transoma Medical Announces First Patient Enrollment in Clinical Study on Long-Term Cardiac Monitoring for Detection of Atrial Fibrillation after Cryptogenic Stroke
Devices Cardiology Monitoring

HSMN NewsFeed - 13 Apr 2009
BIOTRONIK, Inc. Announces The First U.S. Implant Of Lumax 540 Series - A Therapy For Patients Suffering From Heart Failure
Devices Cardiology

HSMN NewsFeed - 23 Mar 2009
FDA Approves Symbyax(R) as First Medication for Treatment-Resistant Depression
Biopharmaceuticals FDA

HSMN NewsFeed - 25 Feb 2009
Aton Pharma Acquires U.S. TIMOPTIC(R)
Biopharmaceuticals Ophthalmology Acquisitions

HSMN NewsFeed - 11 Feb 2009
New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation
Biopharmaceuticals Cardiology

HSMN NewsFeed - 11 Feb 2009
Transoma Medical Receives FDA Marketing Clearance for Sleuth AT Implantable Cardiac Monitoring System
Devices Cardiology Monitoring

HSMN NewsFeed - 20 Jan 2009
Boston Scientific Awarded CRM Contract by Department of Veterans Affairs
Devices Cardiology Group Purchasing

HSMN NewsFeed - 5 Jan 2009
Prism Pharmaceuticals Receives FDA Approval of NEXTERONE(R) for Life-Threatening Ventricular Fibrillation and Ventricular Tachycardia
Biopharmaceuticals Cardiology

HSMN NewsFeed - 6 Nov 2008
FDA Approves Ranexa(R) for First Line Anti Anginal Use and Adds New Claims for Reduction of Ventricular Arrhythmias, Bradycardia, New Atrial Fibrillation and HbA1c
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 7 Oct 2008
St. Jude Medical Celebrates the 50th Anniversary of the World's First Implantable Pacemaker
Devices Cardiology

HSMN NewsFeed - 13 May 2008
Medtronic Announces FDA Approval of New Vision 3D Wireless Implantable Cardiac Devices
Devices Cardiology FDA

HSMN NewsFeed - 8 May 2008
Boston Scientific Announces FDA Approval of New Family of Advanced Pacemakers
Devices Cardiology FDA

HSMN NewsFeed - 7 May 2008
Boston Scientific Announces European Approval and Market Launch of New Family of Advanced Pacemakers
Devices Cardiology

HSMN NewsFeed - 2 Mar 2008
FDA Approves Aloxi(R) (Palonosetron HCL) Injection for Prevention of Postoperative Nausea and Vomiting
Biopharmaceuticals FDA

HSMN NewsFeed - 14 Feb 2008
Spectranetics Appoints Thomas Rasmussen Vice President of Clinical Affairs
Devices Cardiology Personnel

HSMN NewsFeed - 24 Jan 2008
Thalidomide Pharmion(R) Receives Positive Opinion for Treatment of First-line Multiple Myeloma from European Medicines Agency
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 18 Dec 2007
Bystolic(TM), a Novel Beta Blocker, is Now Approved by the FDA for the Treatment of Hypertension
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 12 Dec 2007
Medtronic Implantable Cardiac Monitors Give Physicians Valuable Insights into Heart Rhythms
Devices Cardiology

HSMN NewsFeed - 4 Dec 2007
Sorin Group Cardiac Rhythm Management Announces the First U.S. Enrollment in the Option Study
Devices Cardiology

HSMN NewsFeed - 29 Nov 2007
Sagent Pharmaceuticals Launches Full-Line of Prefilled 6 mg and 12 mg Adenosine Syringes
Biopharmaceuticals

HSMN NewsFeed - 28 Nov 2007
Tasigna(R) gains European approval for patients with a life-threatening form of leukemia who are resistant or intolerant to existing therapies
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 6 Nov 2007
St. Jude Medical Announces One-Year Results from MASCOT Trial
Devices Cardiology

HSMN NewsFeed - 31 Oct 2007
Allergan, Inc. Receives FDA Approval for COMBIGAN(TM) (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5%
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 29 Oct 2007
Tasigna(R) receives US approval providing new hope to chronic myeloid leukemia patients with resistance or intolerance to existing therapies
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 5 Oct 2007
Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels
Biopharmaceuticals

HSMN NewsFeed - 5 Sep 2007
The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia
Biopharmaceuticals Cardiology

HSMN NewsFeed - 5 Sep 2007
New England Journal of Medicine Study Shows Dramatically Reducing Pacing to Right Ventricle Cuts Risk of Persistent Atrial Fibrillation in Pacemaker Patients
Devices Cardiology

HSMN NewsFeed - 9 Aug 2007
Sorin Group: ELA Medical, Inc. Enrolls First Patient in the NATURE Observational Study in the U.S.
Devices Cardiology

HSMN NewsFeed - 26 Jun 2007
New Patient Monitoring System Allows Routine Checkups of Deadly Heart Conditions Using the Internet
Devices Cardiology Monitoring

HSMN NewsFeed - 4 Jun 2007
Pharmion Announces French ATU Granted for Use of Thalidomide for Elderly Patients With Untreated Multiple Myeloma
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 9 May 2007
The Sorin Group Announces European Market Release of REPLY(TM), the World's Smallest Pacemaker
Devices Cardiology

HSMN NewsFeed - 3 May 2007
St. Jude Medical Announces U.S. And European Approvals of Zephyr Pacemaker Family of Devices
Devices Cardiology FDA Regulatory

HSMN NewsFeed - 5 Mar 2007
New Study Finds Commonly Used Heart Monitoring System Often Fails to Detect Serious Cardiac Arrhythmias, a Leading Cause of Stroke and Sudden Cardiac Death
Devices Cardiology Monitoring

HSMN NewsFeed - 1 Mar 2007
EMEA Accepts for Review Thalidomide Pharmion(R) Marketing Authorization Application for Untreated Multiple Myeloma
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 1 Mar 2007
The Sorin Group Announces CE Mark and First Implants of Advanced, Next-Generation Pacemakers in Europe
Devices Regulatory Cardiology

HSMN NewsFeed - 12 Feb 2007
sanofi-aventis Announces Update to U.S. Prescribing Information for Ketek(R) (Telithromycin)
Biopharmaceuticals FDA

HSMN NewsFeed - 23 Jan 2007
Pharmion Submits European Marketing Authorization Application for Thalidomide Pharmion(R) for Untreated Multiple Myeloma
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 21 Nov 2006
Par Pharmaceutical Begins Shipment of Generic TOPROL-XL(R)
Biopharmaceuticals Generics Distribution

HSMN NewsFeed - 7 Nov 2006
St. Jude Medical Announces FDA Approval of New ICD Software for the Merlin(TM) Patient Care System
Devices Cardiology FDA

HSMN NewsFeed - 3 Nov 2006
Arizona Arrhythmia Consultants Seeks Heart Failure Patients For Investigational Study Evaluating Use of New Implantable Pulse Generator
Devices Cardiology

HSMN NewsFeed - 27 Sep 2006
Mortara Instrument, Inc. Announces eCardio Diagnostics as the First Service Provider Offering the New H3+ Holter Monitor for Arrhythmia Assessment
Devices Monitoring Cardiology

HSMN NewsFeed - 29 Jun 2006
sanofi-aventis Announces Update to Ketek(R) (Telithromycin) U.S. Prescribing Information
Biopharmaceuticals FDA

HSMN NewsFeed - 23 May 2006
New Study Suggests Symbyax(R) Significantly Improves Symptoms of Treatment-Resistant Depression
Biopharmaceuticals

HSMN NewsFeed - 22 May 2006
First Head-to-Head Study Suggests Significantly Greater Symptom Improvement for Symbyax(R) Compared to Lamotrigine in Bipolar Depression
Biopharmaceuticals

Return to NewsFeed

Additional items found! 50

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 50 additional stories matching:
Bradycardia
(Password required)

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!